AAAAAA

   
Results: 1-13 |
Results: 13

Authors: VANVLIET IM DENBOER JA WESTENBERG HGM PIAN KLH
Citation: Im. Vanvliet et al., CLINICAL EFFECTS OF BUSPIRONE IN SOCIAL PHOBIA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, The Journal of clinical psychiatry, 58(4), 1997, pp. 164-168

Authors: VANVLIET IM WESTENBERG HGM SLAAP BR DENBOER JA PIAN KLH
Citation: Im. Vanvliet et al., ANXIOGENIC EFFECTS OF PENTAGASTRIN IN PATIENTS WITH SOCIAL PHOBIA ANDHEALTHY CONTROLS, Biological psychiatry, 42(1), 1997, pp. 76-78

Authors: SLAAP BR VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Br. Slaap et al., MHPG AND HEART-RATE AS CORRELATES OF NONRESPONSE TO DRUG-THERAPY IN PANIC DISORDER PATIENTS - A PRELIMINARY-REPORT, Psychopharmacology, 127(4), 1996, pp. 353-358

Authors: VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Im. Vanvliet et al., EFFECTS OF THE 5-HT1A RECEPTOR AGONIST FLESINOXAN IN PANIC DISORDER, Psychopharmacology, 127(2), 1996, pp. 174-180

Authors: VANVLIET IM SLAAP BR WESTENBERG HGM DENBOER JA
Citation: Im. Vanvliet et al., BEHAVIORAL, NEUROENDOCRINE AND BIOCHEMICAL EFFECTS OF DIFFERENT DOSESOF 5-HTP IN PANIC DISORDER, European neuropsychopharmacology, 6(2), 1996, pp. 103-110

Authors: VANVLIET IM DENBOER JA WESTENBERG HGM SLAAP BR
Citation: Im. Vanvliet et al., A DOUBLE-BLIND COMPARATIVE-STUDY OF BROFAROMINE AND FLUVOXAMINE IN OUTPATIENTS WITH PANIC DISORDER, Journal of clinical psychopharmacology, 16(4), 1996, pp. 299-306

Authors: SLAAP BR VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Br. Slaap et al., RESPONDERS AND NONRESPONDERS TO DRUG-TREATMENT IN SOCIAL PHOBIA - DIFFERENCES AT BASE-LINE AND PREDICTION OF RESPONSE, Journal of affective disorders, 39(1), 1996, pp. 13-19

Authors: DENBOER JA VANVLIET IM WESTENBERG HGM
Citation: Ja. Denboer et al., RECENT DEVELOPMENTS IN THE PSYCHOPHARMACOLOGY OF SOCIAL PHOBIA, European archives of psychiatry and clinical neuroscience, 244(6), 1995, pp. 309-316

Authors: DENBOER JA WESTENBERG HGM DELEEUW AS VANVLIET IM
Citation: Ja. Denboer et al., BIOLOGICAL DISSECTION OF ANXIETY DISORDERS - THE CLINICAL ROLE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH PARTICULAR REFERENCE TO FLUVOXAMINE, International clinical psychopharmacology, 9, 1995, pp. 47-52

Authors: SLAAP BR VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Br. Slaap et al., PHOBIC SYMPTOMS AS PREDICTORS OF NONRESPONSE TO DRUG-THERAPY IN PANICDISORDER PATIENTS (A PRELIMINARY-REPORT), Journal of affective disorders, 33(1), 1995, pp. 31-38

Authors: VANVLIET IM DENBOER JA WESTENBERG HGM
Citation: Im. Vanvliet et al., PSYCHOPHARMACOLOGICAL TREATMENT OF SOCIAL PHOBIA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY WITH FLUVOXAMINE, Psychopharmacology, 115(1-2), 1994, pp. 128-134

Authors: DENBOER JA VANVLIET IM WESTENBERG HGM
Citation: Ja. Denboer et al., RECENT ADVANCES IN THE PSYCHOPHARMACOLOGY OF SOCIAL PHOBIA, Progress in neuro-psychopharmacology & biological psychiatry, 18(4), 1994, pp. 625-645

Authors: VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Im. Vanvliet et al., MAO INHIBITORS IN PANIC DISORDER - CLINICAL EFFECTS OF TREATMENT WITHBROFAROMINE - A DOUBLE BLIND PLACEBO CONTROLLED STUDY, Psychopharmacology, 112(4), 1993, pp. 483-489
Risultati: 1-13 |